ETHK Labs Inc. (01931) has updated its shareholders on a repurchase of 145,000 ordinary shares on 15 January 2026. These repurchased shares, acquired at prices ranging from HKD 2.17 to HKD 2.25 per share, are held as treasury shares. The total consideration paid for these shares amounted to HKD 319,820.

The company reported an opening balance on 14 January 2026 of 1,604,954,096 issued shares (excluding treasury shares), with 16,534,000 treasury shares already held, totaling 1,621,488,096 shares. Following the repurchase, the closing balance on 15 January 2026 stands at 1,604,809,096 issued shares (excluding treasury shares) and 16,679,000 treasury shares, maintaining the total at 1,621,488,096 shares. The aggregate number of shares repurchased under the existing mandate now reaches 16,679,000, representing 1.03% of the issued shares as of the mandate resolution date of 30 June 2025.

According to the filing, ETHK Labs Inc. is subject to a moratorium on the issue of new shares or sale of treasury shares until 14 February 2026, unless otherwise permitted by the applicable regulations. No shares were repurchased for cancellation, and there have been no additional treasury share sales.